May 10, 2018 / 11:32 AM / 7 months ago

BRIEF-VBI Vaccines Announces Positive Final Phase 1 Study Results Of Preventative CMV Vaccine

May 10 (Reuters) - VBI Vaccines Inc:

* VBI VACCINES ANNOUNCES POSITIVE FINAL PHASE 1 STUDY RESULTS OF PREVENTATIVE CMV VACCINE

* VBI VACCINES INC - SAFE AND WELL-TOLERATED AT ALL DOSES WITH NO SAFETY SIGNALS OBSERVED IN STUDY

* VBI VACCINES INC - CMV NEUTRALIZING ANTIBODIES AGAINST FIBROBLAST CELL INFECTION INDUCED IN 100% OF SUBJECTS WHO RECEIVED HIGHEST DOSE IN STUDY Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below